nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—Nephrogenic diabetes insipidus—Ifosfamide—germ cell cancer	0.0207	0.0938	CcSEcCtD
Lithium—Clonus—Cisplatin—germ cell cancer	0.0162	0.0736	CcSEcCtD
Lithium—IMPA2—Teniposide—Etoposide—germ cell cancer	0.0146	1	CbGdCrCtD
Lithium—IMPA1—telencephalon—germ cell cancer	0.01	0.0297	CbGeAlD
Lithium—GSK3B—embryo—germ cell cancer	0.00909	0.0269	CbGeAlD
Lithium—GRIA3—telencephalon—germ cell cancer	0.00854	0.0253	CbGeAlD
Lithium—IMPA1—gonad—germ cell cancer	0.00838	0.0248	CbGeAlD
Lithium—GSK3A—trigeminal ganglion—germ cell cancer	0.00819	0.0242	CbGeAlD
Lithium—GSK3B—eye—germ cell cancer	0.00811	0.024	CbGeAlD
Lithium—GSK3B—telencephalon—germ cell cancer	0.00739	0.0219	CbGeAlD
Lithium—IMPA2—skin of body—germ cell cancer	0.00719	0.0213	CbGeAlD
Lithium—IMPA2—decidua—germ cell cancer	0.00714	0.0211	CbGeAlD
Lithium—GSK3A—eye—germ cell cancer	0.00705	0.0209	CbGeAlD
Lithium—GSK3B—decidua—germ cell cancer	0.00701	0.0207	CbGeAlD
Lithium—Polydipsia—Ifosfamide—germ cell cancer	0.007	0.0317	CcSEcCtD
Lithium—GSK3A—retina—germ cell cancer	0.00699	0.0207	CbGeAlD
Lithium—IMPA1—female gonad—germ cell cancer	0.00681	0.0202	CbGeAlD
Lithium—GRIA3—medulla oblongata—germ cell cancer	0.00671	0.0199	CbGeAlD
Lithium—GSK3A—telencephalon—germ cell cancer	0.00643	0.019	CbGeAlD
Lithium—IMPA1—endocrine gland—germ cell cancer	0.00633	0.0187	CbGeAlD
Lithium—IMPA1—head—germ cell cancer	0.00625	0.0185	CbGeAlD
Lithium—GRIA3—adrenal gland—germ cell cancer	0.00621	0.0184	CbGeAlD
Lithium—GSK3B—gonad—germ cell cancer	0.00617	0.0183	CbGeAlD
Lithium—IMPA2—pituitary gland—germ cell cancer	0.00614	0.0182	CbGeAlD
Lithium—GRIA3—midbrain—germ cell cancer	0.00613	0.0181	CbGeAlD
Lithium—GSK3B—uterus—germ cell cancer	0.00613	0.0181	CbGeAlD
Lithium—GSK3A—decidua—germ cell cancer	0.00609	0.018	CbGeAlD
Lithium—IMPA1—testis—germ cell cancer	0.00604	0.0179	CbGeAlD
Lithium—GRIA3—spinal cord—germ cell cancer	0.00598	0.0177	CbGeAlD
Lithium—Papilloedema—Cisplatin—germ cell cancer	0.00589	0.0267	CcSEcCtD
Lithium—GSK3B—medulla oblongata—germ cell cancer	0.00581	0.0172	CbGeAlD
Lithium—IMPA2—adrenal gland—germ cell cancer	0.00548	0.0162	CbGeAlD
Lithium—GSK3B—adrenal gland—germ cell cancer	0.00538	0.0159	CbGeAlD
Lithium—GSK3A—gonad—germ cell cancer	0.00537	0.0159	CbGeAlD
Lithium—GSK3A—uterus—germ cell cancer	0.00533	0.0158	CbGeAlD
Lithium—GRIA3—head—germ cell cancer	0.00532	0.0157	CbGeAlD
Lithium—IMPA2—bone marrow—germ cell cancer	0.0053	0.0157	CbGeAlD
Lithium—GSK3A—pituitary gland—germ cell cancer	0.00523	0.0155	CbGeAlD
Lithium—GSK3B—spinal cord—germ cell cancer	0.00518	0.0153	CbGeAlD
Lithium—GRIA3—testis—germ cell cancer	0.00514	0.0152	CbGeAlD
Lithium—IMPA2—female gonad—germ cell cancer	0.00511	0.0151	CbGeAlD
Lithium—GSK3A—medulla oblongata—germ cell cancer	0.00505	0.0149	CbGeAlD
Lithium—GSK3B—female gonad—germ cell cancer	0.00502	0.0148	CbGeAlD
Lithium—GRIA3—cerebellum—germ cell cancer	0.00474	0.014	CbGeAlD
Lithium—GSK3A—adrenal gland—germ cell cancer	0.00468	0.0138	CbGeAlD
Lithium—GSK3B—endocrine gland—germ cell cancer	0.00466	0.0138	CbGeAlD
Lithium—GSK3A—midbrain—germ cell cancer	0.00462	0.0137	CbGeAlD
Lithium—GSK3B—head—germ cell cancer	0.0046	0.0136	CbGeAlD
Lithium—IMPA2—testis—germ cell cancer	0.00453	0.0134	CbGeAlD
Lithium—IMPA1—brain—germ cell cancer	0.00453	0.0134	CbGeAlD
Lithium—GSK3A—bone marrow—germ cell cancer	0.00452	0.0134	CbGeAlD
Lithium—GSK3A—spinal cord—germ cell cancer	0.0045	0.0133	CbGeAlD
Lithium—GSK3B—testis—germ cell cancer	0.00445	0.0132	CbGeAlD
Lithium—GSK3A—female gonad—germ cell cancer	0.00436	0.0129	CbGeAlD
Lithium—Nystagmus—Vinblastine—germ cell cancer	0.00421	0.0191	CcSEcCtD
Lithium—Slurred speech—Cisplatin—germ cell cancer	0.00419	0.019	CcSEcCtD
Lithium—GSK3B—cerebellum—germ cell cancer	0.00411	0.0122	CbGeAlD
Lithium—GSK3A—endocrine gland—germ cell cancer	0.00406	0.012	CbGeAlD
Lithium—GSK3A—head—germ cell cancer	0.004	0.0118	CbGeAlD
Lithium—GSK3A—testis—germ cell cancer	0.00387	0.0114	CbGeAlD
Lithium—GRIA3—brain—germ cell cancer	0.00385	0.0114	CbGeAlD
Lithium—Folliculitis—Dactinomycin—germ cell cancer	0.00377	0.0171	CcSEcCtD
Lithium—GSK3A—cerebellum—germ cell cancer	0.00357	0.0106	CbGeAlD
Lithium—IMPA2—brain—germ cell cancer	0.0034	0.0101	CbGeAlD
Lithium—Blindness—Cisplatin—germ cell cancer	0.00338	0.0153	CcSEcCtD
Lithium—GSK3B—brain—germ cell cancer	0.00334	0.00987	CbGeAlD
Lithium—IMPA2—lymph node—germ cell cancer	0.00329	0.00973	CbGeAlD
Lithium—Taste metallic—Methotrexate—germ cell cancer	0.00323	0.0146	CcSEcCtD
Lithium—GSK3B—lymph node—germ cell cancer	0.00322	0.00954	CbGeAlD
Lithium—Optic neuritis—Cisplatin—germ cell cancer	0.00304	0.0138	CcSEcCtD
Lithium—Stupor—Ifosfamide—germ cell cancer	0.00291	0.0132	CcSEcCtD
Lithium—GSK3A—brain—germ cell cancer	0.0029	0.00859	CbGeAlD
Lithium—Extrapyramidal disorder—Ifosfamide—germ cell cancer	0.00288	0.0131	CcSEcCtD
Lithium—GSK3A—lymph node—germ cell cancer	0.0028	0.0083	CbGeAlD
Lithium—Optic neuritis—Etoposide—germ cell cancer	0.00279	0.0126	CcSEcCtD
Lithium—Dysarthria—Ifosfamide—germ cell cancer	0.0023	0.0104	CcSEcCtD
Lithium—Muscle twitching—Ifosfamide—germ cell cancer	0.00221	0.01	CcSEcCtD
Lithium—Salivary hypersecretion—Ifosfamide—germ cell cancer	0.00211	0.00956	CcSEcCtD
Lithium—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.0021	0.0095	CcSEcCtD
Lithium—Urinary incontinence—Ifosfamide—germ cell cancer	0.0021	0.0095	CcSEcCtD
Lithium—Coma—Ifosfamide—germ cell cancer	0.00198	0.00899	CcSEcCtD
Lithium—Dysarthria—Cisplatin—germ cell cancer	0.00198	0.00897	CcSEcCtD
Lithium—Urine output increased—Ifosfamide—germ cell cancer	0.00196	0.0089	CcSEcCtD
Lithium—Chest discomfort—Etoposide—germ cell cancer	0.00194	0.00878	CcSEcCtD
Lithium—Polyuria—Ifosfamide—germ cell cancer	0.00179	0.00813	CcSEcCtD
Lithium—Swelling—Ifosfamide—germ cell cancer	0.00179	0.0081	CcSEcCtD
Lithium—Lethargy—Dactinomycin—germ cell cancer	0.00175	0.00795	CcSEcCtD
Lithium—Psoriasis—Methotrexate—germ cell cancer	0.00163	0.00741	CcSEcCtD
Lithium—Folliculitis—Methotrexate—germ cell cancer	0.00163	0.00741	CcSEcCtD
Lithium—Polyuria—Cisplatin—germ cell cancer	0.00155	0.00701	CcSEcCtD
Lithium—Weight decreased—Bleomycin—germ cell cancer	0.00144	0.00654	CcSEcCtD
Lithium—Swelling—Etoposide—germ cell cancer	0.00141	0.00639	CcSEcCtD
Lithium—Stupor—Methotrexate—germ cell cancer	0.00138	0.00624	CcSEcCtD
Lithium—Alopecia—Vinblastine—germ cell cancer	0.00133	0.00605	CcSEcCtD
Lithium—Skin ulcer—Methotrexate—germ cell cancer	0.00132	0.00598	CcSEcCtD
Lithium—Dehydration—Cisplatin—germ cell cancer	0.00126	0.00573	CcSEcCtD
Lithium—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00123	0.00557	CcSEcCtD
Lithium—Vertigo—Vinblastine—germ cell cancer	0.00118	0.00535	CcSEcCtD
Lithium—GSK3B—Presenilin action in Notch and Wnt signaling—MYC—germ cell cancer	0.00118	0.00275	CbGpPWpGaD
Lithium—GSK3B—PI-3K cascade—KIT—germ cell cancer	0.00117	0.00273	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—FGFR3—germ cell cancer	0.00116	0.00271	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—KLF4—germ cell cancer	0.00115	0.0027	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—FGFR3—germ cell cancer	0.00115	0.0027	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—KITLG—germ cell cancer	0.00115	0.00269	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.00115	0.00269	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB2—FGFR3—germ cell cancer	0.00114	0.00268	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—KITLG—germ cell cancer	0.00114	0.00268	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CRABP1—germ cell cancer	0.00114	0.00267	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—FGFR3—germ cell cancer	0.00114	0.00267	CbGpPWpGaD
Lithium—Convulsion—Vinblastine—germ cell cancer	0.00114	0.00516	CcSEcCtD
Lithium—GSK3B—PI3K/AKT activation—KIT—germ cell cancer	0.00114	0.00267	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—KITLG—germ cell cancer	0.00114	0.00267	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—KITLG—germ cell cancer	0.00113	0.00265	CbGpPWpGaD
Lithium—GSK3B—GAB1 signalosome—KIT—germ cell cancer	0.00113	0.00265	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.00113	0.00265	CbGpPWpGaD
Lithium—Alopecia—Bleomycin—germ cell cancer	0.00113	0.00511	CcSEcCtD
Lithium—GSK3B—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—germ cell cancer	0.00112	0.00263	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.00112	0.00263	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.00112	0.00262	CbGpPWpGaD
Lithium—Oliguria—Methotrexate—germ cell cancer	0.00111	0.00505	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB4—KIT—germ cell cancer	0.00111	0.0026	CbGpPWpGaD
Lithium—Bradycardia—Ifosfamide—germ cell cancer	0.00111	0.00503	CcSEcCtD
Lithium—Discomfort—Vinblastine—germ cell cancer	0.00111	0.00501	CcSEcCtD
Lithium—GSK3B—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—germ cell cancer	0.0011	0.00259	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—KLF4—germ cell cancer	0.0011	0.00259	CbGpPWpGaD
Lithium—Dysarthria—Methotrexate—germ cell cancer	0.00109	0.00492	CcSEcCtD
Lithium—Hallucination—Ifosfamide—germ cell cancer	0.00108	0.00492	CcSEcCtD
Lithium—GSK3A—DAP12 interactions—FGFR3—germ cell cancer	0.00107	0.00251	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.00107	0.00251	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.00107	0.00251	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway Netpath—MYC—germ cell cancer	0.00107	0.0025	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—KITLG—germ cell cancer	0.00107	0.0025	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—KITLG—germ cell cancer	0.00107	0.0025	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.00107	0.0025	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—FGFR3—germ cell cancer	0.00106	0.00249	CbGpPWpGaD
Lithium—GSK3A—Downstream signal transduction—KIT—germ cell cancer	0.00106	0.00249	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR—KIT—germ cell cancer	0.00106	0.00247	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—KITLG—germ cell cancer	0.00106	0.00247	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.00105	0.00247	CbGpPWpGaD
Lithium—Alopecia—Dactinomycin—germ cell cancer	0.00105	0.00477	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB2—KIT—germ cell cancer	0.00105	0.00246	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—FGFR3—germ cell cancer	0.00105	0.00246	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.00105	0.00245	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—KIT—germ cell cancer	0.00105	0.00245	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—KITLG—germ cell cancer	0.00104	0.00244	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PVRL2—germ cell cancer	0.00104	0.00243	CbGpPWpGaD
Lithium—GSK3B—ErbB Signaling Pathway—MYC—germ cell cancer	0.00103	0.00242	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.00103	0.00242	CbGpPWpGaD
Lithium—Anorexia—Vinblastine—germ cell cancer	0.00102	0.00464	CcSEcCtD
Lithium—GSK3B—LKB1 signaling events—TP53—germ cell cancer	0.00102	0.00239	CbGpPWpGaD
Lithium—Tinnitus—Ifosfamide—germ cell cancer	0.00102	0.00461	CcSEcCtD
Lithium—GSK3A—B Cell Activation—FGFR3—germ cell cancer	0.000992	0.00232	CbGpPWpGaD
Lithium—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000992	0.0045	CcSEcCtD
Lithium—GSK3B—B Cell Activation—KITLG—germ cell cancer	0.000986	0.00231	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000984	0.00231	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—KIT—germ cell cancer	0.000984	0.00231	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—KIT—germ cell cancer	0.000984	0.00231	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—KITLG—germ cell cancer	0.000982	0.0023	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—H2AFZ—germ cell cancer	0.000981	0.0023	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—KIT—germ cell cancer	0.000975	0.00228	CbGpPWpGaD
Lithium—Arrhythmia—Ifosfamide—germ cell cancer	0.000974	0.00441	CcSEcCtD
Lithium—GSK3A—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000967	0.00226	CbGpPWpGaD
Lithium—Alopecia—Ifosfamide—germ cell cancer	0.000963	0.00437	CcSEcCtD
Lithium—GSK3A—Signaling by PDGF—KIT—germ cell cancer	0.000962	0.00225	CbGpPWpGaD
Lithium—Bradycardia—Cisplatin—germ cell cancer	0.000957	0.00434	CcSEcCtD
Lithium—GSK3B—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.00095	0.00223	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—germ cell cancer	0.000949	0.00222	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000949	0.00222	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000944	0.00221	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—AVP—germ cell cancer	0.000941	0.0022	CbGpPWpGaD
Lithium—Coma—Methotrexate—germ cell cancer	0.000938	0.00425	CcSEcCtD
Lithium—GSK3B—Notch Signaling Pathway—MYC—germ cell cancer	0.000938	0.0022	CbGpPWpGaD
Lithium—Discomfort—Bleomycin—germ cell cancer	0.000934	0.00423	CcSEcCtD
Lithium—Decreased appetite—Vinblastine—germ cell cancer	0.000933	0.00423	CcSEcCtD
Lithium—Urine output increased—Methotrexate—germ cell cancer	0.000929	0.00421	CcSEcCtD
Lithium—Confusional state—Bleomycin—germ cell cancer	0.000914	0.00414	CcSEcCtD
Lithium—GSK3A—B Cell Activation—KIT—germ cell cancer	0.000911	0.00213	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000909	0.00213	CbGpPWpGaD
Lithium—Oedema—Bleomycin—germ cell cancer	0.000906	0.00411	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB4—FGFR3—germ cell cancer	0.000895	0.0021	CbGpPWpGaD
Lithium—Vision blurred—Ifosfamide—germ cell cancer	0.000894	0.00405	CcSEcCtD
Lithium—Feeling abnormal—Vinblastine—germ cell cancer	0.000884	0.00401	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—FGF4—germ cell cancer	0.000884	0.00207	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—H2AFZ—germ cell cancer	0.000882	0.00207	CbGpPWpGaD
Lithium—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000877	0.00398	CcSEcCtD
Lithium—Tinnitus—Cisplatin—germ cell cancer	0.000876	0.00397	CcSEcCtD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000876	0.00205	CbGpPWpGaD
Lithium—GSK3B—Copper homeostasis—TP53—germ cell cancer	0.000875	0.00205	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—KIT—germ cell cancer	0.000872	0.00204	CbGpPWpGaD
Lithium—Agitation—Ifosfamide—germ cell cancer	0.000872	0.00395	CcSEcCtD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000872	0.00204	CbGpPWpGaD
Lithium—Discomfort—Dactinomycin—germ cell cancer	0.000871	0.00395	CcSEcCtD
Lithium—GSK3B—Wnt Signaling Pathway—MYC—germ cell cancer	0.00087	0.00204	CbGpPWpGaD
Lithium—Angioedema—Ifosfamide—germ cell cancer	0.000867	0.00393	CcSEcCtD
Lithium—Anorexia—Bleomycin—germ cell cancer	0.000864	0.00392	CcSEcCtD
Lithium—GSK3B—Downstream signal transduction—FGFR3—germ cell cancer	0.000854	0.002	CbGpPWpGaD
Lithium—Vertigo—Ifosfamide—germ cell cancer	0.000853	0.00386	CcSEcCtD
Lithium—GSK3B—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—germ cell cancer	0.00085	0.00199	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—FGFR3—germ cell cancer	0.00085	0.00199	CbGpPWpGaD
Lithium—GSK3B—ErbB Signaling Pathway—TP53—germ cell cancer	0.000849	0.00199	CbGpPWpGaD
Lithium—Polyuria—Methotrexate—germ cell cancer	0.000849	0.00385	CcSEcCtD
Lithium—Abdominal pain—Vinblastine—germ cell cancer	0.000848	0.00384	CcSEcCtD
Lithium—Hypotension—Bleomycin—germ cell cancer	0.000847	0.00384	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB2—FGFR3—germ cell cancer	0.000846	0.00198	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—HRAS—germ cell cancer	0.000845	0.00198	CbGpPWpGaD
Lithium—Oedema—Dactinomycin—germ cell cancer	0.000845	0.00383	CcSEcCtD
Lithium—GSK3B—DAP12 signaling—FGFR3—germ cell cancer	0.000842	0.00197	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—H2AFZ—germ cell cancer	0.000841	0.00197	CbGpPWpGaD
Lithium—Arrhythmia—Cisplatin—germ cell cancer	0.00084	0.00381	CcSEcCtD
Lithium—GSK3B—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000835	0.00196	CbGpPWpGaD
Lithium—Alopecia—Cisplatin—germ cell cancer	0.000831	0.00376	CcSEcCtD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.00083	0.00194	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000826	0.00374	CcSEcCtD
Lithium—Convulsion—Ifosfamide—germ cell cancer	0.000822	0.00373	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB4—KIT—germ cell cancer	0.000821	0.00192	CbGpPWpGaD
Lithium—GSK3B—ErbB Signaling Pathway—HRAS—germ cell cancer	0.000812	0.0019	CbGpPWpGaD
Lithium—Arthralgia—Ifosfamide—germ cell cancer	0.000808	0.00366	CcSEcCtD
Lithium—Flatulence—Cisplatin—germ cell cancer	0.000806	0.00365	CcSEcCtD
Lithium—Anorexia—Dactinomycin—germ cell cancer	0.000806	0.00365	CcSEcCtD
Lithium—Discomfort—Ifosfamide—germ cell cancer	0.000798	0.00362	CcSEcCtD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000792	0.00186	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—FGFR3—germ cell cancer	0.000792	0.00186	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000792	0.00186	CbGpPWpGaD
Lithium—GSK3B—p53 pathway—TP53—germ cell cancer	0.000791	0.00185	CbGpPWpGaD
Lithium—Decreased appetite—Bleomycin—germ cell cancer	0.000788	0.00357	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR—FGFR3—germ cell cancer	0.000785	0.00184	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—KIT—germ cell cancer	0.000784	0.00184	CbGpPWpGaD
Lithium—Confusional state—Ifosfamide—germ cell cancer	0.000781	0.00354	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR—KIT—germ cell cancer	0.000781	0.00183	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000778	0.00182	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—SOX2—germ cell cancer	0.000778	0.00182	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—KIT—germ cell cancer	0.000777	0.00182	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—FGFR3—germ cell cancer	0.000775	0.00181	CbGpPWpGaD
Lithium—Oedema—Ifosfamide—germ cell cancer	0.000775	0.00351	CcSEcCtD
Lithium—GSK3B—DAP12 signaling—KIT—germ cell cancer	0.000773	0.00181	CbGpPWpGaD
Lithium—Vision blurred—Cisplatin—germ cell cancer	0.000771	0.0035	CcSEcCtD
Lithium—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00077	0.00349	CcSEcCtD
Lithium—Asthenia—Vinblastine—germ cell cancer	0.00077	0.00349	CcSEcCtD
Lithium—Tremor—Cisplatin—germ cell cancer	0.000767	0.00347	CcSEcCtD
Lithium—GSK3B—Adaptive Immune System—PVRL2—germ cell cancer	0.000766	0.00179	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000762	0.00178	CbGpPWpGaD
Lithium—Alopecia—Etoposide—germ cell cancer	0.000761	0.00345	CcSEcCtD
Lithium—Lethargy—Methotrexate—germ cell cancer	0.000761	0.00345	CcSEcCtD
Lithium—Feeling abnormal—Bleomycin—germ cell cancer	0.000747	0.00339	CcSEcCtD
Lithium—Anorexia—Ifosfamide—germ cell cancer	0.000738	0.00335	CcSEcCtD
Lithium—Decreased appetite—Dactinomycin—germ cell cancer	0.000735	0.00333	CcSEcCtD
Lithium—Diarrhoea—Vinblastine—germ cell cancer	0.000734	0.00333	CcSEcCtD
Lithium—Dysgeusia—Etoposide—germ cell cancer	0.000734	0.00333	CcSEcCtD
Lithium—GSK3B—B Cell Activation—FGFR3—germ cell cancer	0.000733	0.00172	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—FGFR3—germ cell cancer	0.00073	0.00171	CbGpPWpGaD
Lithium—Fatigue—Dactinomycin—germ cell cancer	0.000729	0.0033	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR in disease—KIT—germ cell cancer	0.000727	0.0017	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000727	0.0017	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—KIT—germ cell cancer	0.000727	0.0017	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—H2AFZ—germ cell cancer	0.000727	0.0017	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—KITLG—germ cell cancer	0.000726	0.0017	CbGpPWpGaD
Lithium—Hypotension—Ifosfamide—germ cell cancer	0.000724	0.00328	CcSEcCtD
Lithium—GSK3B—Signaling by EGFR—KIT—germ cell cancer	0.000721	0.00169	CbGpPWpGaD
Lithium—Body temperature increased—Bleomycin—germ cell cancer	0.000716	0.00325	CcSEcCtD
Lithium—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000716	0.00168	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000714	0.00167	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—KIT—germ cell cancer	0.000711	0.00167	CbGpPWpGaD
Lithium—Dizziness—Vinblastine—germ cell cancer	0.00071	0.00322	CcSEcCtD
Lithium—GSK3B—LPA receptor mediated events—HRAS—germ cell cancer	0.000709	0.00166	CbGpPWpGaD
Lithium—Convulsion—Cisplatin—germ cell cancer	0.000709	0.00321	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000706	0.0032	CcSEcCtD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000702	0.00164	CbGpPWpGaD
Lithium—Ataxia—Methotrexate—germ cell cancer	0.000701	0.00318	CcSEcCtD
Lithium—GRIA3—BDNF signaling pathway—HRAS—germ cell cancer	0.0007	0.00164	CbGpPWpGaD
Lithium—Feeling abnormal—Dactinomycin—germ cell cancer	0.000697	0.00316	CcSEcCtD
Lithium—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000691	0.00313	CcSEcCtD
Lithium—Somnolence—Ifosfamide—germ cell cancer	0.000689	0.00312	CcSEcCtD
Lithium—Discomfort—Cisplatin—germ cell cancer	0.000688	0.00312	CcSEcCtD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000688	0.00161	CbGpPWpGaD
Lithium—Vomiting—Vinblastine—germ cell cancer	0.000682	0.00309	CcSEcCtD
Lithium—GSK3A—Innate Immune System—FGF4—germ cell cancer	0.000682	0.0016	CbGpPWpGaD
Lithium—Vertigo—Etoposide—germ cell cancer	0.000673	0.00305	CcSEcCtD
Lithium—Decreased appetite—Ifosfamide—germ cell cancer	0.000673	0.00305	CcSEcCtD
Lithium—GSK3B—B Cell Activation—KIT—germ cell cancer	0.000673	0.00158	CbGpPWpGaD
Lithium—Headache—Vinblastine—germ cell cancer	0.000672	0.00305	CcSEcCtD
Lithium—GSK3A—Signaling by NGF—KIT—germ cell cancer	0.00067	0.00157	CbGpPWpGaD
Lithium—Body temperature increased—Dactinomycin—germ cell cancer	0.000668	0.00303	CcSEcCtD
Lithium—Abdominal pain—Dactinomycin—germ cell cancer	0.000668	0.00303	CcSEcCtD
Lithium—Fatigue—Ifosfamide—germ cell cancer	0.000668	0.00303	CcSEcCtD
Lithium—Oedema—Cisplatin—germ cell cancer	0.000668	0.00303	CcSEcCtD
Lithium—GSK3B—CDC42 signaling events—HRAS—germ cell cancer	0.00066	0.00155	CbGpPWpGaD
Lithium—Loss of consciousness—Etoposide—germ cell cancer	0.000659	0.00299	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—FGF4—germ cell cancer	0.000655	0.00153	CbGpPWpGaD
Lithium—Asthenia—Bleomycin—germ cell cancer	0.00065	0.00295	CcSEcCtD
Lithium—Convulsion—Etoposide—germ cell cancer	0.000649	0.00294	CcSEcCtD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000647	0.00152	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000644	0.00151	CbGpPWpGaD
Lithium—GSK3A—Disease—SLC2A3—germ cell cancer	0.000639	0.0015	CbGpPWpGaD
Lithium—Feeling abnormal—Ifosfamide—germ cell cancer	0.000638	0.00289	CcSEcCtD
Lithium—Nausea—Vinblastine—germ cell cancer	0.000637	0.00289	CcSEcCtD
Lithium—Anorexia—Cisplatin—germ cell cancer	0.000637	0.00289	CcSEcCtD
Lithium—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000633	0.00287	CcSEcCtD
Lithium—Discomfort—Etoposide—germ cell cancer	0.000631	0.00286	CcSEcCtD
Lithium—GSK3A—Immune System—PVRL2—germ cell cancer	0.000629	0.00147	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—MYC—germ cell cancer	0.000627	0.00147	CbGpPWpGaD
Lithium—GSK3B—Alzheimers Disease—TP53—germ cell cancer	0.000627	0.00147	CbGpPWpGaD
Lithium—GSK3B—Leptin signaling pathway—HRAS—germ cell cancer	0.000625	0.00146	CbGpPWpGaD
Lithium—Hypotension—Cisplatin—germ cell cancer	0.000624	0.00283	CcSEcCtD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—MYC—germ cell cancer	0.000622	0.00146	CbGpPWpGaD
Lithium—Confusional state—Etoposide—germ cell cancer	0.000617	0.0028	CcSEcCtD
Lithium—GSK3A—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000615	0.00144	CbGpPWpGaD
Lithium—Body temperature increased—Ifosfamide—germ cell cancer	0.000612	0.00278	CcSEcCtD
Lithium—Abdominal pain—Ifosfamide—germ cell cancer	0.000612	0.00278	CcSEcCtD
Lithium—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000608	0.00276	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	0.000608	0.00142	CbGpPWpGaD
Lithium—Asthenia—Dactinomycin—germ cell cancer	0.000606	0.00275	CcSEcCtD
Lithium—Erectile dysfunction—Methotrexate—germ cell cancer	0.000593	0.00269	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—MYC—germ cell cancer	0.00059	0.00138	CbGpPWpGaD
Lithium—Anorexia—Etoposide—germ cell cancer	0.000583	0.00264	CcSEcCtD
Lithium—Decreased appetite—Cisplatin—germ cell cancer	0.00058	0.00263	CcSEcCtD
Lithium—Diarrhoea—Dactinomycin—germ cell cancer	0.000578	0.00262	CcSEcCtD
Lithium—Vomiting—Bleomycin—germ cell cancer	0.000576	0.00261	CcSEcCtD
Lithium—Drowsiness—Methotrexate—germ cell cancer	0.000575	0.0026	CcSEcCtD
Lithium—Hypotension—Etoposide—germ cell cancer	0.000572	0.00259	CcSEcCtD
Lithium—Rash—Bleomycin—germ cell cancer	0.000571	0.00259	CcSEcCtD
Lithium—Dermatitis—Bleomycin—germ cell cancer	0.000571	0.00259	CcSEcCtD
Lithium—GSK3A—Innate Immune System—KITLG—germ cell cancer	0.00056	0.00131	CbGpPWpGaD
Lithium—Asthenia—Ifosfamide—germ cell cancer	0.000556	0.00252	CcSEcCtD
Lithium—Feeling abnormal—Cisplatin—germ cell cancer	0.00055	0.00249	CcSEcCtD
Lithium—Somnolence—Etoposide—germ cell cancer	0.000544	0.00247	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—FGFR3—germ cell cancer	0.00054	0.00126	CbGpPWpGaD
Lithium—Nausea—Bleomycin—germ cell cancer	0.000538	0.00244	CcSEcCtD
Lithium—GRIA3—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000538	0.00126	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—KITLG—germ cell cancer	0.000538	0.00126	CbGpPWpGaD
Lithium—Vomiting—Dactinomycin—germ cell cancer	0.000537	0.00244	CcSEcCtD
Lithium—Rash—Dactinomycin—germ cell cancer	0.000533	0.00242	CcSEcCtD
Lithium—Decreased appetite—Etoposide—germ cell cancer	0.000532	0.00241	CcSEcCtD
Lithium—Diarrhoea—Ifosfamide—germ cell cancer	0.00053	0.0024	CcSEcCtD
Lithium—Body temperature increased—Cisplatin—germ cell cancer	0.000528	0.00239	CcSEcCtD
Lithium—Fatigue—Etoposide—germ cell cancer	0.000527	0.00239	CcSEcCtD
Lithium—Dizziness—Ifosfamide—germ cell cancer	0.000512	0.00232	CcSEcCtD
Lithium—GSK3B—Cell Cycle—TP53—germ cell cancer	0.000511	0.0012	CbGpPWpGaD
Lithium—GSK3B—Wnt Signaling Pathway and Pluripotency—TP53—germ cell cancer	0.000511	0.0012	CbGpPWpGaD
Lithium—GSK3A—Signaling by SCF-KIT—HRAS—germ cell cancer	0.00051	0.0012	CbGpPWpGaD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000509	0.00119	CbGpPWpGaD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000508	0.00119	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000505	0.00118	CbGpPWpGaD
Lithium—Feeling abnormal—Etoposide—germ cell cancer	0.000504	0.00228	CcSEcCtD
Lithium—GSK3B—Innate Immune System—FGF4—germ cell cancer	0.000504	0.00118	CbGpPWpGaD
Lithium—Nausea—Dactinomycin—germ cell cancer	0.000502	0.00228	CcSEcCtD
Lithium—Gastrointestinal pain—Etoposide—germ cell cancer	0.0005	0.00227	CcSEcCtD
Lithium—GSK3B—Senescence and Autophagy in Cancer—TP53—germ cell cancer	0.000499	0.00117	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—KIT—germ cell cancer	0.000495	0.00116	CbGpPWpGaD
Lithium—Vomiting—Ifosfamide—germ cell cancer	0.000492	0.00223	CcSEcCtD
Lithium—Rash—Ifosfamide—germ cell cancer	0.000488	0.00221	CcSEcCtD
Lithium—GSK3A—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000488	0.00114	CbGpPWpGaD
Lithium—Dermatitis—Ifosfamide—germ cell cancer	0.000488	0.00221	CcSEcCtD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—TP53—germ cell cancer	0.000484	0.00113	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGF4—germ cell cancer	0.000484	0.00113	CbGpPWpGaD
Lithium—Body temperature increased—Etoposide—germ cell cancer	0.000484	0.00219	CcSEcCtD
Lithium—Abdominal pain—Etoposide—germ cell cancer	0.000484	0.00219	CcSEcCtD
Lithium—Tinnitus—Methotrexate—germ cell cancer	0.000481	0.00218	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB4—HRAS—germ cell cancer	0.00048	0.00113	CbGpPWpGaD
Lithium—Asthenia—Cisplatin—germ cell cancer	0.000479	0.00217	CcSEcCtD
Lithium—GSK3B—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	0.000477	0.00112	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC2A3—germ cell cancer	0.000472	0.00111	CbGpPWpGaD
Lithium—GSK3B—Immune System—PVRL2—germ cell cancer	0.000465	0.00109	CbGpPWpGaD
Lithium—GSK3B—DNA Damage Response (only ATM dependent)—HRAS—germ cell cancer	0.000463	0.00109	CbGpPWpGaD
Lithium—GSK3A—Insulin Signaling—HRAS—germ cell cancer	0.000461	0.00108	CbGpPWpGaD
Lithium—Nausea—Ifosfamide—germ cell cancer	0.00046	0.00209	CcSEcCtD
Lithium—GSK3A—Downstream signal transduction—HRAS—germ cell cancer	0.000459	0.00107	CbGpPWpGaD
Lithium—Diarrhoea—Cisplatin—germ cell cancer	0.000457	0.00207	CcSEcCtD
Lithium—GSK3A—Signaling by FGFR—HRAS—germ cell cancer	0.000457	0.00107	CbGpPWpGaD
Lithium—Alopecia—Methotrexate—germ cell cancer	0.000456	0.00207	CcSEcCtD
Lithium—GSK3A—Signaling by ERBB2—HRAS—germ cell cancer	0.000454	0.00106	CbGpPWpGaD
Lithium—GSK3A—DAP12 signaling—HRAS—germ cell cancer	0.000452	0.00106	CbGpPWpGaD
Lithium—GSK3A—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000446	0.00104	CbGpPWpGaD
Lithium—Dysgeusia—Methotrexate—germ cell cancer	0.00044	0.00199	CcSEcCtD
Lithium—Asthenia—Etoposide—germ cell cancer	0.000439	0.00199	CcSEcCtD
Lithium—GSK3A—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000425	0.000996	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000425	0.000996	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—HRAS—germ cell cancer	0.000425	0.000996	CbGpPWpGaD
Lithium—Vomiting—Cisplatin—germ cell cancer	0.000425	0.00192	CcSEcCtD
Lithium—Vision blurred—Methotrexate—germ cell cancer	0.000423	0.00192	CcSEcCtD
Lithium—GSK3A—Signaling by EGFR—HRAS—germ cell cancer	0.000421	0.000987	CbGpPWpGaD
Lithium—Rash—Cisplatin—germ cell cancer	0.000421	0.00191	CcSEcCtD
Lithium—Dermatitis—Cisplatin—germ cell cancer	0.000421	0.00191	CcSEcCtD
Lithium—Diarrhoea—Etoposide—germ cell cancer	0.000419	0.0019	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000418	0.00098	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000418	0.000979	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FGFR3—germ cell cancer	0.000416	0.000976	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—HRAS—germ cell cancer	0.000416	0.000974	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—KITLG—germ cell cancer	0.000414	0.00097	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—HRAS—germ cell cancer	0.000412	0.000966	CbGpPWpGaD
Lithium—Dizziness—Etoposide—germ cell cancer	0.000405	0.00183	CcSEcCtD
Lithium—Vertigo—Methotrexate—germ cell cancer	0.000403	0.00183	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—FGFR3—germ cell cancer	0.0004	0.000937	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—KITLG—germ cell cancer	0.000398	0.000931	CbGpPWpGaD
Lithium—GSK3A—Immune System—FGF4—germ cell cancer	0.000397	0.000931	CbGpPWpGaD
Lithium—Nausea—Cisplatin—germ cell cancer	0.000397	0.0018	CcSEcCtD
Lithium—GSK3A—B Cell Activation—HRAS—germ cell cancer	0.000394	0.000922	CbGpPWpGaD
Lithium—Convulsion—Methotrexate—germ cell cancer	0.000389	0.00176	CcSEcCtD
Lithium—Vomiting—Etoposide—germ cell cancer	0.000389	0.00176	CcSEcCtD
Lithium—Rash—Etoposide—germ cell cancer	0.000386	0.00175	CcSEcCtD
Lithium—Dermatitis—Etoposide—germ cell cancer	0.000385	0.00175	CcSEcCtD
Lithium—Headache—Etoposide—germ cell cancer	0.000383	0.00174	CcSEcCtD
Lithium—GSK3A—Innate Immune System—KIT—germ cell cancer	0.000382	0.000896	CbGpPWpGaD
Lithium—Arthralgia—Methotrexate—germ cell cancer	0.000382	0.00173	CcSEcCtD
Lithium—Discomfort—Methotrexate—germ cell cancer	0.000378	0.00171	CcSEcCtD
Lithium—GSK3B—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000377	0.000883	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000377	0.000882	CbGpPWpGaD
Lithium—GSK3B—BDNF signaling pathway—HRAS—germ cell cancer	0.000371	0.000868	CbGpPWpGaD
Lithium—Confusional state—Methotrexate—germ cell cancer	0.000369	0.00167	CcSEcCtD
Lithium—GSK3A—Adaptive Immune System—KIT—germ cell cancer	0.000367	0.00086	CbGpPWpGaD
Lithium—GSK3A—Disease—FGF4—germ cell cancer	0.000367	0.000859	CbGpPWpGaD
Lithium—Nausea—Etoposide—germ cell cancer	0.000363	0.00165	CcSEcCtD
Lithium—GSK3B—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000361	0.000845	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—HRAS—germ cell cancer	0.000355	0.000832	CbGpPWpGaD
Lithium—Anorexia—Methotrexate—germ cell cancer	0.000349	0.00158	CcSEcCtD
Lithium—Hypotension—Methotrexate—germ cell cancer	0.000342	0.00155	CcSEcCtD
Lithium—GSK3B—Insulin Signaling—HRAS—germ cell cancer	0.000341	0.000798	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—HRAS—germ cell cancer	0.000339	0.000794	CbGpPWpGaD
Lithium—GSK3B—TCF dependent signaling in response to WNT—MYC—germ cell cancer	0.000339	0.000793	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—HRAS—germ cell cancer	0.000337	0.00079	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—HRAS—germ cell cancer	0.000336	0.000786	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—HRAS—germ cell cancer	0.000334	0.000783	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000334	0.00151	CcSEcCtD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000329	0.000771	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—MYC—germ cell cancer	0.000328	0.000768	CbGpPWpGaD
Lithium—GSK3A—Disease—H2AFZ—germ cell cancer	0.000328	0.000767	CbGpPWpGaD
Lithium—GSK3A—Immune System—KITLG—germ cell cancer	0.000326	0.000765	CbGpPWpGaD
Lithium—Somnolence—Methotrexate—germ cell cancer	0.000326	0.00148	CcSEcCtD
Lithium—Dyspepsia—Methotrexate—germ cell cancer	0.000323	0.00146	CcSEcCtD
Lithium—Decreased appetite—Methotrexate—germ cell cancer	0.000319	0.00144	CcSEcCtD
Lithium—Fatigue—Methotrexate—germ cell cancer	0.000316	0.00143	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000314	0.000736	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—HRAS—germ cell cancer	0.000314	0.000736	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000314	0.000736	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—HRAS—germ cell cancer	0.000311	0.00073	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000309	0.000723	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FGFR3—germ cell cancer	0.000308	0.000721	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—HRAS—germ cell cancer	0.000307	0.00072	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—MYC—germ cell cancer	0.000305	0.000713	CbGpPWpGaD
Lithium—Feeling abnormal—Methotrexate—germ cell cancer	0.000302	0.00137	CcSEcCtD
Lithium—GSK3A—Disease—KITLG—germ cell cancer	0.000301	0.000706	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—OXT—germ cell cancer	0.000301	0.000705	CbGpPWpGaD
Lithium—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0003	0.00136	CcSEcCtD
Lithium—GSK3B—Focal Adhesion—HRAS—germ cell cancer	0.000297	0.000696	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—TP53—germ cell cancer	0.000297	0.000695	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—FGFR3—germ cell cancer	0.000296	0.000692	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGF4—germ cell cancer	0.000294	0.000688	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—HRAS—germ cell cancer	0.000291	0.000681	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—HRAS—germ cell cancer	0.00029	0.000679	CbGpPWpGaD
Lithium—Abdominal pain—Methotrexate—germ cell cancer	0.00029	0.00131	CcSEcCtD
Lithium—Body temperature increased—Methotrexate—germ cell cancer	0.00029	0.00131	CcSEcCtD
Lithium—GSK3B—Innate Immune System—KIT—germ cell cancer	0.000283	0.000662	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000278	0.000652	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—KIT—germ cell cancer	0.000271	0.000636	CbGpPWpGaD
Lithium—GSK3B—Disease—FGF4—germ cell cancer	0.000271	0.000635	CbGpPWpGaD
Lithium—Asthenia—Methotrexate—germ cell cancer	0.000263	0.00119	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—FGF4—germ cell cancer	0.000257	0.000602	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—MYC—germ cell cancer	0.000251	0.000588	CbGpPWpGaD
Lithium—Diarrhoea—Methotrexate—germ cell cancer	0.000251	0.00114	CcSEcCtD
Lithium—GSK3A—Immune System—FGFR3—germ cell cancer	0.000243	0.000568	CbGpPWpGaD
Lithium—Dizziness—Methotrexate—germ cell cancer	0.000242	0.0011	CcSEcCtD
Lithium—GSK3B—Disease—H2AFZ—germ cell cancer	0.000242	0.000567	CbGpPWpGaD
Lithium—GSK3B—Immune System—KITLG—germ cell cancer	0.000241	0.000565	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—TP53—germ cell cancer	0.000239	0.000559	CbGpPWpGaD
Lithium—Vomiting—Methotrexate—germ cell cancer	0.000233	0.00106	CcSEcCtD
Lithium—Rash—Methotrexate—germ cell cancer	0.000231	0.00105	CcSEcCtD
Lithium—Dermatitis—Methotrexate—germ cell cancer	0.000231	0.00105	CcSEcCtD
Lithium—Headache—Methotrexate—germ cell cancer	0.00023	0.00104	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—H2AFZ—germ cell cancer	0.000229	0.000537	CbGpPWpGaD
Lithium—GSK3A—Disease—FGFR3—germ cell cancer	0.000224	0.000525	CbGpPWpGaD
Lithium—GSK3A—Immune System—KIT—germ cell cancer	0.000223	0.000522	CbGpPWpGaD
Lithium—GSK3B—Disease—KITLG—germ cell cancer	0.000223	0.000522	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—OXT—germ cell cancer	0.000222	0.000521	CbGpPWpGaD
Lithium—Nausea—Methotrexate—germ cell cancer	0.000218	0.000987	CcSEcCtD
Lithium—GSK3B—Signaling by NGF—HRAS—germ cell cancer	0.000214	0.000502	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KITLG—germ cell cancer	0.000211	0.000494	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AVP—germ cell cancer	0.000206	0.000483	CbGpPWpGaD
Lithium—GSK3A—Disease—KIT—germ cell cancer	0.000206	0.000482	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—HRAS—germ cell cancer	0.000194	0.000454	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGF4—germ cell cancer	0.00019	0.000445	CbGpPWpGaD
Lithium—GSK3B—Immune System—FGFR3—germ cell cancer	0.000179	0.00042	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—H2AFZ—germ cell cancer	0.000169	0.000397	CbGpPWpGaD
Lithium—GSK3B—Disease—FGFR3—germ cell cancer	0.000165	0.000388	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—HRAS—germ cell cancer	0.000165	0.000387	CbGpPWpGaD
Lithium—GSK3B—Immune System—KIT—germ cell cancer	0.000165	0.000386	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HRAS—germ cell cancer	0.000159	0.000372	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FGFR3—germ cell cancer	0.000157	0.000367	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KITLG—germ cell cancer	0.000156	0.000365	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AVP—germ cell cancer	0.000152	0.000357	CbGpPWpGaD
Lithium—GSK3B—Disease—KIT—germ cell cancer	0.000152	0.000356	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—KIT—germ cell cancer	0.000144	0.000337	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—HRAS—germ cell cancer	0.000138	0.000324	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HRAS—germ cell cancer	0.000122	0.000286	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HRAS—germ cell cancer	0.000117	0.000275	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FGFR3—germ cell cancer	0.000116	0.000271	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—germ cell cancer	0.000113	0.000265	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—KIT—germ cell cancer	0.000106	0.000249	CbGpPWpGaD
Lithium—GSK3A—Immune System—HRAS—germ cell cancer	9.62e-05	0.000225	CbGpPWpGaD
Lithium—GSK3A—Disease—HRAS—germ cell cancer	8.89e-05	0.000208	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—germ cell cancer	8.36e-05	0.000196	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—germ cell cancer	7.92e-05	0.000186	CbGpPWpGaD
Lithium—GSK3B—Immune System—HRAS—germ cell cancer	7.11e-05	0.000167	CbGpPWpGaD
Lithium—GSK3B—Disease—HRAS—germ cell cancer	6.57e-05	0.000154	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TP53—germ cell cancer	6.51e-05	0.000152	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HRAS—germ cell cancer	6.22e-05	0.000146	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—germ cell cancer	5.85e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TP53—germ cell cancer	4.81e-05	0.000113	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HRAS—germ cell cancer	4.6e-05	0.000108	CbGpPWpGaD
